*Other Operating Data Consensus Source: Bloomberg
More on Abbott Laboratories
- Abbott Laboratories: Q4 Earnings On The Horizon
- Abbott: Not Cheap, But Built To Compound In Uncertain Markets
- Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise
- Abbott Laboratories Q4 2025 Earnings Preview
- Abbott wins FDA approval of Volt pulsed ablation device for atrial fibrillation